Table 2. Comparison of four-year mortality and repeat revascularization in left anterior descending artery for hybrid coronary revascularization and percutaneous coronary intervention for pre-selected patient subgroups: New York, 2010−2016.
| Subgroup | Prevalence | Mortality | Repeat revascularization in LAD | |||||
| In HCR | In PCI | Hazard ratio
(95% CI) of HCR/PCI |
P-value for interaction | Hazard ratio
(95% CI) of HCR/PCI |
P-value for interaction | |||
| BMI: body mass index; HCR: hybrid coronary revascularization; LAD: left anterior descending; MI: myocardial infarction; PCI: percutaneous coronary interventions. | ||||||||
| All cases | 100.00% | 100.00% | 0.90 (0.67−1.20) | 0.51 (0.34−0.77) | ||||
| Age ≥ 75 yrs | 19.70% | 23.68% | 1.03 (0.67−1.59) | 0.52 | 0.80 (0.33−1.94) | 0.36 | ||
| Age < 75 yrs | 80.30% | 76.32% | 0.82 (0.55−1.22) | 0.49 (0.31−0.76) | ||||
| Female | 21.49% | 28.60% | 0.54 (0.27−1.08) | 0.07 | 0.68 (0.32−1.44) | 0.43 | ||
| Male | 78.51% | 71.40% | 1.08 (0.78−1.49) | 0.48 (0.30−0.77) | ||||
| BMI < 25 kg/m 2 | 27.76% | 21.67% | 0.63 (0.36−1.12) | 0.003 | 0.49 (0.20−1.18) | 0.90 | ||
| BMI ≥ 25 and < 35 kg/m 2 | 62.09% | 62.99% | 1.42 (1.00−2.03) | 0.54 (0.33−0.90) | ||||
| BMI ≥ 35 kg/m2 | 10.15% | 15.33% | 0.30 (0.10−0.93) | 0.52 (0.19−1.40) | ||||
| Ejection fraction ≤ 50% | 25.37% | 28.12% | 0.81 (0.50−1.32) | 0.39 | 0.70 (0.35−1.41) | 0.36 | ||
| Ejection fraction > 50% | 74.63% | 71.88% | 0.94 (0.65−1.36) | 0.46 (0.28−0.75) | ||||
| MI within 20 days | 28.96% | 37.53% | 0.76 (0.44−1.32) | 0.44 | 0.54 (0.24−1.20) | 0.97 | ||
| No MI within 20 days | 71.04% | 62.47% | 0.93 (0.66−1.32) | 0.53 (0.33−0.84) | ||||
| Previous PCI procedure, yes | 17.01% | 17.08% | 1.21 (0.64−2.28) | 0.39 | 0.39 (0.15−1.05) | 0.49 | ||
| Previous PCI procedure, no | 82.99% | 82.92% | 0.83 (0.60−1.16) | 0.56 (0.36−0.86) | ||||
| Congestive heart failure, yes | 12.54% | 9.71% | 0.63 (0.35−1.12) | 0.24 | NA (NA−NA) | 0.88 | ||
| Congestive heart failure, no | 87.46% | 90.29% | 1.01 (0.72−1.42) | 0.62 (0.42−0.93) | ||||
| Chronic lung disease, yes | 4.78% | 5.72% | 0.53 (0.23−1.19) | 0.21 | 0.43 (0.06−3.09) | 0.88 | ||
| Chronic lung disease, no | 95.22% | 94.28% | 1.00 (0.73−1.37) | 0.53 (0.35−0.80) | ||||
| Cerebrovascular disease, yes | 10.15% | 8.63% | 1.14 (0.62−2.10) | 0.37 | 0.43 (0.11−1.73) | 0.74 | ||
| Cerebrovascular disease, no | 89.85% | 91.37% | 0.84 (0.60−1.17) | 0.52 (0.34−0.79) | ||||
| Peripheral vascular disease, yes | 8.36% | 7.31% | 0.76 (0.38−1.55) | 0.87 | 0.23 (0.03−1.64) | 0.35 | ||
| Peripheral vascular disease,no | 91.64% | 92.69% | 0.92 (0.66−1.26) | 0.57 (0.37−0.85) | ||||
| Diabetes requiring medication, yes | 35.52% | 34.05% | 0.64 (0.39−1.05) | 0.10 | 0.45 (0.24−0.84) | 0.59 | ||
| Diabetes requiring medication, no | 64.48% | 65.95% | 1.10 (0.76−1.58) | 0.60 (0.35−1.01) | ||||
| Creatinine > 1.5 mg/dL or require renal dialysis | 6.86% | 8.38% | 1.22 (0.72−2.09) | 0.42 | NA (NA−NA) | 0.88 | ||
| Creatinine ≤ 1.5 mg/dL | 93.14% | 91.62% | 0.83 (0.58−1.17) | 0.58 (0.39−0.86) | ||||
| 3-vessel disease, yes | 51.94% | 35.18% | 0.73 (0.49−1.08) | 0.15 | 0.39 (0.21−0.74) | 0.19 | ||
| 3-vessel disease, no | 48.06% | 64.82% | 1.16 (0.76−1.79) | 0.68 (0.40−1.15) | ||||
| Proximal LAD disease, yes | 69.25% | 42.49% | 0.97 (0.69−1.38) | 0.19 | 0.54 (0.33−0.87) | 0.81 | ||
| Proximal LAD disease, no | 30.75% | 57.51% | 0.73 (0.42−1.27) | 0.51 (0.24−1.08) | ||||
| LMT disease, yes | 13.43% | 2.41% | 1.02 (0.55−1.91) | 0.36 | 0.35 (0.11−1.11) | 0.50 | ||
| LMT disease, no | 86.57% | 97.59% | 0.85 (0.61−1.18) | 0.56 (0.37−0.87) | ||||